Subscribe to RSS

Johnson & Johnson TB Drug Given Clearance

Posted on 03. Jan, 2013 by in Health, Health Featured

Johnson

The new drug, Sirturo, will help treat those patients that have Multidrug Resistant TB or MDR-TB

January 3, 2013 - The Johnson & Johnson drug to help treat a resistant form of tuberculosis was given fast track clearance by the U.S. Food and Drug Administration. The form of TB is still uncommon in the United States, but is growing around the world.

The new drug, Sirturo, will help treat those patients that have Multidrug Resistant TB or MDR-TB. The disease can be fatal and affects up to 630,000 people worldwide who cannot be cured with therapies that exist today.

Tuberculosis is an infection caused by bacteria and attacks mostly the lungs. Sirturo, also called bedaquiline, is not thought to be a big moneymaker for J&J, one of the largest healthcare conglomerates in the world, because TB is mainly prevalent in the world’s poorer nations that are unable to afford treatments that have high prices.

However, providing the new treatment could help J&J create enormous goodwill amongst regulators, patients and governments across the globe.

A spokesperson for J&J said the commercial opportunity for the drug was limited, but it was part of the company’s commitment to advance new and innovative medicines that are able to help address issues of public health that are very serious.

J&J said Sirturo should be ready to sell during the second quarter of this year and did not announce what the sales price was. Less than 100 people in the U.S. suffer from MDR-TB, according to Johnson & Johnson. However, the FDA approval will help strengthen the chances for the drug’s approval in regions of the world where the disease has become more prevalent including Eastern Europe, China and India.

Nevertheless, the drug has
potential risks that include an increased chance of death and that raised questions amongst members of the U.S. regulatory agency. A prominent warning label must be placed on the new drug that informs patients that take Sirturo that clinical trials show an increased rate of fatalities.

 

0 comments

Other articlesgo to homepage

AbbVie Beats Estimates during First Quarter

AbbVie Beats Estimates during First Quarter(0)

April 28, 2013 - AbbVie announced on Friday that it could earn up to $1.5 billion more in annual revenue from is rheumatoid arthritis medication Humira, which already makes up 50% of its overall revenue, as new uses are approved for the medication. Humira’s sales during the first quarter were up by 16% from the same

Vaccine Trial for HIV Shuttered

Vaccine Trial for HIV Shuttered(0)

April 26, 2013- Federal researchers have shuttered a clinical trial for a vaccine for HIV that involved more than 2,500 subjects. The trial was ended after researchers found that it was ineffective at preventing subjects who were healthy from contracting HIV. The major setback came about when safety experts from an independent panel determined that

Hundreds of Undocumented Immigrants Sent Home by Hospitals in U.S.

Hundreds of Undocumented Immigrants Sent Home by Hospitals in U.S.(0)

April 24, 2013 - Hundreds of immigrants that were in the U.S. illegally have been transported back to their home countries by hospitals in the U.S. This little known or heard off system of removal is not run by the government, but by individual hospitals who seek to lower their costs. A report recently published compiled

AIDS: 1.8 million children orphaned in Nigeria

AIDS: 1.8 million children orphaned in Nigeria(0)

April 21, 2013 - Medical experts estimate that over 1.8 million children in Nigeria have been orphaned because of AIDS since 1986 when the first case was identified of the pandemic in the country. The Ministry of Health in the country spoke of the problems the children are facing during a five-day workshop to help give

Authorities accuse Glaxo of Paying to delay Generic Medicines

Authorities accuse Glaxo of Paying to delay Generic Medicines(0)

April 19, 2013 - GlaxoSmithKline the UK pharmaceutical giant was accused of paying their rivals to slow production of generic versions of the company’s most profitable antidepressant medication. The Office of Fair Trading in Britain has launched the investigation into the alleged payoffs by GSK to keep the sales of its drug Seroxat high. The alleged

read more

Headlines

Genocide Trial in Guatemalan Suspended Genocide Trial in Guatemalan Suspended
One Suspect in Boston Killed, one on the run One Suspect in Boston Killed, one on the run
Musharraf Flees as Bail is Revoked Musharraf Flees as Bail is Revoked
Some Say New Immigration Bill too Stringent Some Say New Immigration Bill too Stringent
read more

Sponsors